- Email: [email protected]
Oxford Catalysts interim report 1H 2012
FOCUS 2013 and 2014, as was the case in 2011. This is particularly due to lower than hoped for sales of enzymes for bioenergy production. Demand has been hit by reduced investment in the bioethanol industry combined with drought and a sharp rise in maize prices in America as well as insufficient political support for the further development of the bioethanol industry. Novozymes’ long term growth target is 10%. Original Source: NP Investor, 24 Oct 2012, (Website: http://www.npinvestor.dk/) (in Danish) © NPinvestor A/S 2012
Novozymes sales by product area 3Q 2012 Novozymes’ sales of bioenergy enzymes totalled DKR 424 M in 3Q 2012, 1.6% less than forecast by Sydbank and 5.1% lower than market expectations. For washing product enzymes sales were 13.5% higher in 3Q 2012 than in 3Q 2011, and the sales growth was 16% for feed enzymes. Sydbank expects washing product and feed enzymes to be Novozymes’ growth engine for the remainder of 2012 as well as for 2013. Original Source: NP Investor, 25 Oct 2012, (Website: http://www.npinvestor.dk/) (in Danish) © NPinvestor A/S 2012
Novozymes results 3Q 2012 Novozymes reported a sales growth of 5% to DKR 2.84 bn for 3Q 2012. Analysts had predicted DKR 2.91 bn. Ebit was up 14% to SKR 720 M; the forecast was SKR 689 M. For washing product enzymes there was a 14% growth in sales to DKR 989 M and for the division BioBusiness, which supplies microorganisms to agriculture and biopharmaceutical products to the drug industry, sales fell by 2% to DKR 424 M. For feed enzymes there was a 16% increase in sales to DKR 405 M. Novozymes has reduced its sales growth forecast for the whole of 2012 from 7-9% to 7%, with the organic sales growth forecast being cut from 4-6% to 4%. It is maintaining its prediction of an 1114% increase in results from primary operations for 2012. Original Source: NP Investor, 25 Oct 2012, (Website: http://www.npinvestor.dk/) (in Danish) © NPinvestor A/S 2012
4
ON
C ATA LY S T S
Oxford Catalysts interim report 1H 2012
Oxford Catalysts Group interim report 1H 2012: intellectual property
Oxford Catalysts’ revenues during 1H 2012 were £3.64 M (up from £2.946 M in 1H 2011), primarily from development funding from the group’s partners as well as certain government grants. Gross profit was £1.432 M (up from £1.152 M in 1H 2011). Operating losses were £5.066 M (compared with £5.41 M in 1H 2011). Losses for the period were £4.871 M (compared with £3.842 M in 1H 2011). Cash outflow in 1H 2012 was £5.0 M (compared with £4.3 M in 1H 2011) and Oxford Catalysts expects the 2H 2012 figure to be similar. At 30 Jun 2012 the group had £12.1 M of cash (down from £17.1 M as of 30 Jun 2011). Management is closely overseeing the group’s drive for early sales and speed to market, to ensure continued responsible stewardship of the group’s financial resources.
Oxford Catalysts’ current intellectual property portfolio includes 800+ active patent cases and an even larger number of invention records. During 1H 2012 the group filed 2 new patent applications, while 37 existing applications were granted in jurisdictions including the US, Australia, Canada, China, Japan, S Africa, S Korea, and various European countries. This patent portfolio is one of the group’s key strengths and it continues to invest and protect this significant asset, including enforcement to safeguard the group’s business interests. Oxford Catalysts owns or exclusively controls 25,000+ granted or pending patent claims, which cover a variety of embodiments of processes, reactors and catalysts based on 15+ years of development.
Original Source: Oxford Catalysts, 115E-H Milton Park, Abingdon, Oxfordshire OX14 4RZ, UK, tel: +44 (0)1235 841 70, fax: +44 (0)1235 841 701, email: [email protected], website: http://www.oxfordcatalysts.com/ (21 Sep 2012) © Oxford Catalysts Group plc 2012
Oxford Catalysts interim report 1H 2012: commercialization Oxford Catalysts now considers its FT reactor as commercially ready, having been successfully demonstrated at full scale. This is evidenced by the selection of its technology for various projects in 1H 2012. In May, the group announced the selection of its technology for a small-scale GTL facility commissioned by Rosneft (Russia’s largest oil producer). Rosneft announced a partnership with technology commercialisation firm Gazohim Techno, to design and construct a GTL plant using the group’s FT technology, with a capacity of at least 10 M cu m/y natural gas (equivalent to approximately 100 barrels/d synthetic crude). The plant will be located at the Angarsk Petrochemical Company site, and is expected to be complete by end 2014. Original Source: Oxford Catalysts, 115E-H Milton Park, Abingdon, Oxfordshire OX14 4RZ, UK, tel: +44 (0)1235 841 70, fax: +44 (0)1235 841 701, email: [email protected], website: http://www.oxfordcatalysts.com/ (21 Sep 2012) © Oxford Catalysts Group plc 2012
Original Source: Oxford Catalysts, 115E-H Milton Park, Abingdon, Oxfordshire OX14 4RZ, UK, tel: +44 (0)1235 841 70, fax: +44 (0)1235 841 701, email: [email protected], website: http://www.oxfordcatalysts.com/ (21 Sep 2012) © Oxford Catalysts Group plc 2012
Petronas to help convert carbon dioxide into chemicals Petronas and LanzaTech have jointly announced a collaboration to step up the development and commercialization of technologies for production of chemicals from carbon dioxide and natural gas. The partners will work on extending LanzaTech’s fermentation technology to convert carbon dioxide from natural gas wells and refinery off-gases to produce acetic acid, which is used in making plastics and polymer. At present, LanzaTech’s fermentation process transforms carbon monoxide from reformed natural gas, industrial waste gas and biomass-derived gases into low-carbon fuels and chemicals. Pilot projects for the company’s original process are ongoing in the USA, India, and China with partners including the US Defense Advanced Research Projects Agency, Indian Oil, Mitsui Baosteel, and Henan Coal & Chemical Industrial Corp. Original Source: TCE (formerly The Chemical Engineer), Nov 2012, (857), 20-21 (Website: http://www.tcetoday.com) © Institution of Chemical Engineers 2012
JANUARY 2013
Novozymes sales by product area 3Q 2012 Novozymes’ sales of bioenergy enzymes totalled DKR 424 M in 3Q 2012, 1.6% less than forecast by Sydbank and 5.1% lower than market expectations. For washing product enzymes sales were 13.5% higher in 3Q 2012 than in 3Q 2011, and the sales growth was 16% for feed enzymes. Sydbank expects washing product and feed enzymes to be Novozymes’ growth engine for the remainder of 2012 as well as for 2013. Original Source: NP Investor, 25 Oct 2012, (Website: http://www.npinvestor.dk/) (in Danish) © NPinvestor A/S 2012
Novozymes results 3Q 2012 Novozymes reported a sales growth of 5% to DKR 2.84 bn for 3Q 2012. Analysts had predicted DKR 2.91 bn. Ebit was up 14% to SKR 720 M; the forecast was SKR 689 M. For washing product enzymes there was a 14% growth in sales to DKR 989 M and for the division BioBusiness, which supplies microorganisms to agriculture and biopharmaceutical products to the drug industry, sales fell by 2% to DKR 424 M. For feed enzymes there was a 16% increase in sales to DKR 405 M. Novozymes has reduced its sales growth forecast for the whole of 2012 from 7-9% to 7%, with the organic sales growth forecast being cut from 4-6% to 4%. It is maintaining its prediction of an 1114% increase in results from primary operations for 2012. Original Source: NP Investor, 25 Oct 2012, (Website: http://www.npinvestor.dk/) (in Danish) © NPinvestor A/S 2012
4
ON
C ATA LY S T S
Oxford Catalysts interim report 1H 2012
Oxford Catalysts Group interim report 1H 2012: intellectual property
Oxford Catalysts’ revenues during 1H 2012 were £3.64 M (up from £2.946 M in 1H 2011), primarily from development funding from the group’s partners as well as certain government grants. Gross profit was £1.432 M (up from £1.152 M in 1H 2011). Operating losses were £5.066 M (compared with £5.41 M in 1H 2011). Losses for the period were £4.871 M (compared with £3.842 M in 1H 2011). Cash outflow in 1H 2012 was £5.0 M (compared with £4.3 M in 1H 2011) and Oxford Catalysts expects the 2H 2012 figure to be similar. At 30 Jun 2012 the group had £12.1 M of cash (down from £17.1 M as of 30 Jun 2011). Management is closely overseeing the group’s drive for early sales and speed to market, to ensure continued responsible stewardship of the group’s financial resources.
Oxford Catalysts’ current intellectual property portfolio includes 800+ active patent cases and an even larger number of invention records. During 1H 2012 the group filed 2 new patent applications, while 37 existing applications were granted in jurisdictions including the US, Australia, Canada, China, Japan, S Africa, S Korea, and various European countries. This patent portfolio is one of the group’s key strengths and it continues to invest and protect this significant asset, including enforcement to safeguard the group’s business interests. Oxford Catalysts owns or exclusively controls 25,000+ granted or pending patent claims, which cover a variety of embodiments of processes, reactors and catalysts based on 15+ years of development.
Original Source: Oxford Catalysts, 115E-H Milton Park, Abingdon, Oxfordshire OX14 4RZ, UK, tel: +44 (0)1235 841 70, fax: +44 (0)1235 841 701, email: [email protected], website: http://www.oxfordcatalysts.com/ (21 Sep 2012) © Oxford Catalysts Group plc 2012
Oxford Catalysts interim report 1H 2012: commercialization Oxford Catalysts now considers its FT reactor as commercially ready, having been successfully demonstrated at full scale. This is evidenced by the selection of its technology for various projects in 1H 2012. In May, the group announced the selection of its technology for a small-scale GTL facility commissioned by Rosneft (Russia’s largest oil producer). Rosneft announced a partnership with technology commercialisation firm Gazohim Techno, to design and construct a GTL plant using the group’s FT technology, with a capacity of at least 10 M cu m/y natural gas (equivalent to approximately 100 barrels/d synthetic crude). The plant will be located at the Angarsk Petrochemical Company site, and is expected to be complete by end 2014. Original Source: Oxford Catalysts, 115E-H Milton Park, Abingdon, Oxfordshire OX14 4RZ, UK, tel: +44 (0)1235 841 70, fax: +44 (0)1235 841 701, email: [email protected], website: http://www.oxfordcatalysts.com/ (21 Sep 2012) © Oxford Catalysts Group plc 2012
Original Source: Oxford Catalysts, 115E-H Milton Park, Abingdon, Oxfordshire OX14 4RZ, UK, tel: +44 (0)1235 841 70, fax: +44 (0)1235 841 701, email: [email protected], website: http://www.oxfordcatalysts.com/ (21 Sep 2012) © Oxford Catalysts Group plc 2012
Petronas to help convert carbon dioxide into chemicals Petronas and LanzaTech have jointly announced a collaboration to step up the development and commercialization of technologies for production of chemicals from carbon dioxide and natural gas. The partners will work on extending LanzaTech’s fermentation technology to convert carbon dioxide from natural gas wells and refinery off-gases to produce acetic acid, which is used in making plastics and polymer. At present, LanzaTech’s fermentation process transforms carbon monoxide from reformed natural gas, industrial waste gas and biomass-derived gases into low-carbon fuels and chemicals. Pilot projects for the company’s original process are ongoing in the USA, India, and China with partners including the US Defense Advanced Research Projects Agency, Indian Oil, Mitsui Baosteel, and Henan Coal & Chemical Industrial Corp. Original Source: TCE (formerly The Chemical Engineer), Nov 2012, (857), 20-21 (Website: http://www.tcetoday.com) © Institution of Chemical Engineers 2012
JANUARY 2013